跳至主要内容
临床试验/NCT03296358
NCT03296358已完成不适用

A Randomized, Double-blinded, Controlled Trial of Adding a Short Burst of Corticosteroid to the Conventional Treatment of H1 Antihistamines

Chulalongkorn University1 个研究点 分布在 1 个国家目标入组 75 人开始时间: 2017年10月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
75
试验地点
1
主要终点
Itch score

研究概览

简要总结

A randomized, double-blinded, controlled trial of adding a short burst of corticosteroid to the conventional treatment of H1 antihistamines

详细描述

Research Methodology

Target Population Patients visit emergency room at King chulalongkorn memorial hospital (KCMH) age between 18-50 years who meet the following criteria of acute urticarial such as

  1. eruption of wheals, central swelling of various sizes, with or without surrounding erythema; with or without angioedema
  2. pruritus or occasional burning sensation
  3. skin returning to normal appearance, usually within 1-24 hours

Exclusion criteria

  1. patients who have urticarial for more than 48 hours
  2. have severe underlying disease such as heart disease, kidney disease, liver disease
  3. pregnancy
  4. history of Chlorpheniramine, steroid, antihistamines allergy
  5. history of antihistamine or steroid uses within 48 hours before emergency department visit
  6. diabetes mellitus
  7. suspected of more severe disease or severe allergic reaction
  8. patients who don't have pruritus
  9. patients who have history of chronic urticaria

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Patients visit emergency room at King chulalongkorn memorial hospital (KCMH) age between 18-50 years who meet the following criteria of acute urticarial such as
  • eruption of wheals, central swelling of various sizes, with or without surrounding erythema; with or without angioedema
  • pruritus or occasional burning sensation
  • skin returning to normal appearance, usually within 1-24 hours

排除标准

  • patients who have urticarial for more than 48 hours
  • have severe underlying disease such as heart disease, kidney disease, liver disease
  • history of chlorpheniramine maleate, steroid, antihistamines allergy
  • history of antihistamine or steroid uses within 48 hours before ED visit
  • diabetes mellitus
  • suspected of more severe disease or severe allergic reaction
  • patients who don't have pruritus
  • patients who have history of chronic urticaria

研究组 & 干预措施

Experiment 1

Experimental

Chlorpheniramine 10 mg/amp ; 1 ampule, IV Dexamethasone 5 mg/amp; 1 ampule Cetirizine 10 mg 7 tabs 1 tab OD as home medication

干预措施: IV Dexamethasone (Drug)

Experiment 2

Experimental

Chlorpheniramine 10 mg/amp ; 1 ampule, IV Dexamethasone 5 mg/amp; 1 ampule Cetirizine 10 mg 7 tabs 1 tab OD as home medication Oral prednisolone 5 mg 20 tabs ; 2*2 po pc as home medication

干预措施: IV Dexamethasone (Drug)

Experiment 2

Experimental

Chlorpheniramine 10 mg/amp ; 1 ampule, IV Dexamethasone 5 mg/amp; 1 ampule Cetirizine 10 mg 7 tabs 1 tab OD as home medication Oral prednisolone 5 mg 20 tabs ; 2*2 po pc as home medication

干预措施: Oral prednisolone (Drug)

结局指标

主要结局

Itch score

时间窗: 60 mins

letting the patients mark a cross on a straight line. The end of the left side of a line represents "0 = no itch at all", and the end of the right side of a line represents "10 = the worst itch ever possible". The patients aren't allowed to compare the previous VAS score before doing the cross.

次要结局

  • Chronic urticaria incidence(1 week, 1 month)
  • Itch score(0, 15, 30 mins)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验